Multi-gene Testing for Ovarian Cancer Risk is Clinically Us...
Multi-gene Testing for Ovarian Cancer Risk is Clinically Useful
(August 21, 2015) A study published online in JAMA Oncology this month shows that screening women with a suspected risk of hereditary breast or ovarian cancer with a multigene panel (which looks for mutations in many genes), identifies more people with cancer risk related gene mutations than screening for BRCA1 and 2 alone. Importantly, identifying … Continued